Fundraising Fox

Ali Tehrani

Investor

Entrepreneur in Residence at Amplitude Venture Capital

Vancouver, British Columbia, Canada

About

Entrepreneur in Residence at Amplitude (joined 2022). Co-founded Zymeworks Inc. and served as its President & CEO from 2003 to 2022, leading its NYSE IPO and multiple pharma partnerships. Holds BSc and MSc degrees from the University of Massachusetts and a doctorate from UBC.

Experience

  1. DCx Biotherapeutics CorporationCo-Founder & CEOcurrent2024 — presentCanada
  2. QurCan Therapeutics Inc.Board Membercurrent2022 — present
  3. Amplitude VenturesPartner2023 — 2025Vancouver, British Columbia, Canada
  4. Amplitude VenturesVenture Partner2022Vancouver, British Columbia, Canada
  5. Reverb TherapeuticsBoard Member2023 — 2024Canada
  6. Creatus Biosciences Inc.Board Member2015 — 2023
  7. ZymeworksCo-founder, President & CEO2003 — 2022Vancouver, British Columbia, Canada

Education

  1. The University of British ColumbiaPhD, Microbiology and Immunology1997 — 2003
  2. University of Massachusetts AmherstM.S., Biochemistry1994 — 1996
  3. University of Massachusetts AmherstBachelor of Applied Science - BASc, Biochemistry1990 — 1994

Skills & more

Protein Engineering33Protein Chemistry36Molecular Modeling17Antibodies19Biotechnology21Enzymes10Pharmaceutical Industry12Lifesciences10Drug Discovery16Immunology9Technology Transfer19Biochemistry12
+9 moreMolecular BiologyBiopharmaceuticalsCommercializationMonoclonal AntibodiesTeam LeadershipLife SciencesDrug DevelopmentStrategyStart-ups

From Ali's professional profile.

Same school

Shared employers

Colleagues at Amplitude Venture Capital